Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users.
While neuropsychological studies on 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) users have been emerging, results have been inconsistent, possibly due to methodological issues. The current study examined the performance of 22 recreational MDMA users compared to 28 age, education, and IQ comparable normal control subjects on a comprehensive battery of neuropsychological tests. Results revealed no significant differences in cognitive functioning between the MDMA users and normal controls. However, greater use of MDMA was associated with poorer scores on several measures of nonverbal memory, and greater frequency users (> or = 50 times) evidenced significantly lower scores on 2 of 3 nonverbal memory tests compared to lesser frequency users (< 50 times). Our results suggest that a subgroup of MDMA patients, specifically heavy MDMA users, evidence declines in nonverbal (visual) memory, however, other cognitive areas appear to be spared.
Back-Madruga
Carla
C
Department of Psychiatry, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA. cback@hsc.usc.edu
Boone
Kyle B
KB
Chang
Linda
L
Grob
Charles S
CS
Lee
Allison
A
Nations
Heather
H
Poland
Russell E
RE
D000328:Adult; D016022:Case-Control Studies; D005260:Female; D006213:Hallucinogens / Q000494:pharmacology*; D006801:Humans; D013287:Illicit Drugs / Q000494:pharmacology; D007360:Intelligence / Q000187:drug effects; D007361:Intelligence Tests / Q000706:statistics & numerical data; D007802:Language; D008297:Male; D008606:Mental Processes / Q000187:drug effects*; D008875:Middle Aged; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000494:pharmacology*; D009483:Neuropsychological Tests / Q000706:statistics & numerical data*; D011597:Psychomotor Performance / Q000187:drug effects*
D006213:Hallucinogens; D013287:Illicit Drugs; D018817:N-Methyl-3,4-methylenedioxyamphetamine